Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients

NCT00120198 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

50

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: CDOP plus rituximab

Sponsor

Geriatric Oncology Consortium

Collaborators

[object Object]